Our innovative products and technologies define a new era in current and future diagnostic and therapeutic radiopharmaceuticals.
We lead the way in producing stable, reliable, domestically-sourced, environmentally-friendly radioisotope supply to meet critical patient healthcare needs and advance clinical research.
Our people drive our solutions in advancing radioisotope technology to shape a better world.
We are a recognized, emerging global leader with a proven track record and strong vision for the future of radiopharmaceuticals. Our innovation-driven technology is transforming the landscape for medical radioisotope production and distribution around the world.
NorthStar Medical Radioisotopes Sets New Industry Precedent in Advancing Non-uranium based Commercial Production of Molybdenum-99 (Mo-99)
Read More >NorthStar Medical Radioisotopes and Inhibrx Enter into Collaboration Agreement for the Development and Production of Radiopharmaceutical Candidates
Read More >NorthStar Medical Radioisotopes Statement on Availability of Technetium 99m Generators and the FDA Drug Shortages List
Read More >NorthStar Medical Radioisotopes Expands Business Platform with New, Patient-focused, Radiopharmaceutical Contract Development and Manufacturing Organization (CDMO) Services Unit
Read More >